A leading contract research organization (CRO) dedicated to ophthalmology, Iris Pharma helps clients around the world navigate every stage of the drug and device development process – including in vivo screening, proof of concept, ocular efficacy, GLP preclinical studies, bioanalysis, clinical trials, and marketing surveys. Iris Pharma has partnered with clients to bring nearly 70 ocular drugs and medical devices to market in the past 26 years, in addition to offering consulting services to help clients determine the best indication for molecules and products in development. This CRO has expertise in all ophthalmic indications, and supports clients ranging from small start-ups to large pharmaceutical companies in moving forward products that directly or indirectly affect eye health.
Iris Pharma, partner of The Institut de la Vision.
In the context of the joint cooperation with the Institut de la Vision, Iris Pharma's main tasks are:
- to act as a link between the academic and industrial sectors in order to implement new industrial partnerships and reinforce the continuum from the stage of the underlying research through to treatment of visually impaired patients.
- to develop research programs in collaboration with the Institut de la Vision, mainly for the purpose of offering new services and industrial innovations to its clients.
- to implement industrial standards in the Institut de la Vision's technical support center that comply with Good Laboratory Practice (GLP).
In order to bring these various activities to fruition, Iris Pharma has its own premises in the Institut de la Vision building and participates in the Steering Committee.
Read more clicking here
